Eucrates Biomedi Stock Price, News & Analysis
Company Description
Eucrates Biomedi (NASDAQ: EUCR) is a publicly traded shell companies company in the Financial Services sector. The company has a market capitalization of $42.2M.
EUCR stock has gained 1.4% over the past year.
This page provides a comprehensive overview of EUCR stock, including real-time price data, latest news, SEC filings, insider trading activity, financial highlights, upcoming events, and short interest trends.
Stock Performance
Eucrates Biomedi (EUCR) stock. Over the past 12 months, the stock has gained 1.4%. At a market capitalization of $42.2M, EUCR is classified as a micro-cap stock with approximately 4.2M shares outstanding.
Latest News
Eucrates Biomedi has 2 recent news articles. Of the recent coverage, 0 articles coincided with positive price movement and 2 with negative movement. Key topics include acquisition. View all EUCR news →
SEC Filings
Financial Highlights
Upcoming Events
Short Interest History
Days to Cover History
EUCR Company Profile & Sector Positioning
Eucrates Biomedi (EUCR) operates in the Shell Companies industry within the broader Financial Services sector and is listed on the NASDAQ.
Investors comparing EUCR often look at related companies in the same sector, including DUET ACQUISITION CORP (DUET), ESH Acquisition Corp (ESHA), Jatt Ii Acquisition Corp (JATT), Republic Digital Acquisition (RDAGU), and Quetta Acquisition (QETA). Comparing financial metrics, valuation ratios, and stock performance across these peers can help investors evaluate EUCR's relative position within its industry.